These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 29996796
1. Association between low bone mass and the serum RANKL and OPG in patients with nephrolithiasis. Mansour A, Aboeerad M, Qorbani M, Hashemi Taheri AP, Pajouhi M, Keshtkar AA, Larijani B, Mohajeri-Tehrani MR, Ganji MR. BMC Nephrol; 2018 Jul 11; 19(1):172. PubMed ID: 29996796 [Abstract] [Full Text] [Related]
2. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis. Tsentidis C, Gourgiotis D, Kossiva L, Doulgeraki A, Marmarinos A, Galli-Tsinopoulou A, Karavanaki K. Osteoporos Int; 2016 Apr 11; 27(4):1631-1643. PubMed ID: 26588909 [Abstract] [Full Text] [Related]
3. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory. Nabipour I, Larijani B, Vahdat K, Assadi M, Jafari SM, Ahmadi E, Movahed A, Moradhaseli F, Sanjdideh Z, Obeidi N, Amiri Z. Menopause; 2009 Apr 11; 16(5):950-5. PubMed ID: 19387415 [Abstract] [Full Text] [Related]
4. Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis. Xu S, Wang Y, Lu J, Xu J. Rheumatol Int; 2012 Nov 11; 32(11):3397-403. PubMed ID: 22057136 [Abstract] [Full Text] [Related]
6. Serum RANKL, osteoprotegerin (OPG) and RANKL/OPG ratio in children with systemic lupus erythematosus. Ali R, Hammad A, El-Nahrery E, Hamdy N, Elhawary AK, Eid R. Lupus; 2019 Sep 11; 28(10):1233-1242. PubMed ID: 31403902 [Abstract] [Full Text] [Related]
9. Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women. Shang M, Lin L, Cui H. Clin Biochem; 2013 Oct 11; 46(15):1493-501. PubMed ID: 23531404 [Abstract] [Full Text] [Related]
10. Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients. Doumouchtsis KK, Kostakis AI, Doumouchtsis SK, Tziamalis MP, Stathakis CP, Diamanti-Kandarakis E, Dimitroulis D, Perrea DN. J Bone Miner Metab; 2008 Oct 11; 26(1):66-72. PubMed ID: 18095066 [Abstract] [Full Text] [Related]
12. Imbalance of osteoprotegerin/receptor activator of nuclear factor-κB ligand and oxidative stress in patients with obstructive sleep apnea-hypopnea syndrome. Ma XR, Wang Y, Sun YC. Chin Med J (Engl); 2019 Jan 05; 132(1):25-29. PubMed ID: 30628956 [Abstract] [Full Text] [Related]
17. Relationships between OPG, RANKL, bone metabolism, and bone mineral density in biliary atresia. Honsawek S, Chaiwatanarat T, Vejchapipat P, Chongsrisawat V, Thawornsuk N, Poovorawan Y. Pediatr Surg Int; 2009 Mar 05; 25(3):261-7. PubMed ID: 19184056 [Abstract] [Full Text] [Related]
19. Relationships between insulin-like growth factor-I (IGF-I) and OPG, RANKL, bone mineral density in healthy Chinese women. Zhao HY, Liu JM, Ning G, Zhao YJ, Chen Y, Sun LH, Zhang LZ, Xu MY, Chen JL. Osteoporos Int; 2008 Feb 05; 19(2):221-6. PubMed ID: 17703270 [Abstract] [Full Text] [Related]
20. Associations of Bone Mineral Density with RANKL and Osteoprotegerin in Arab Postmenopausal Women: A Cross-Sectional Study. Amer OE, Wani K, Ansari MGA, Alnaami AM, Aljohani N, Abdi S, Hussain SD, Al-Daghri NM, Alokail MS. Medicina (Kaunas); 2022 Jul 22; 58(8):. PubMed ID: 35893092 [Abstract] [Full Text] [Related] Page: [Next] [New Search]